Operator-led. Method second.
Biomavens is a boutique firm focused on improving decision quality and execution across commercial, human, and AI-enabled systems. Led by a senior operator with three decades of work — much of it inside healthcare and life sciences, which remains a core credibility domain — the method is the result of repeatedly seeing where organizations struggle to turn capability into execution, not the starting point.
Why Biomavens sees decisions and execution differently.
Biomavens was built from a pattern repeated across commercial, human, and AI-enabled systems: real capability, credible platforms, strong teams, meaningful revenue — and decisions and execution that still struggle to compound.
The missing layer is rarely another feature or another claim. It's the connection between what the organization can do and what its leaders, buyers, and operators are actually trying to decide — translated into a clear motion the team can run.
Most advisors live in strategy or in execution. Biomavens was built at the intersection — and hardened inside healthcare and life sciences, where decision quality and execution have to survive procurement, clinical, financial, and operating reality.
Biomavens helps organizations move from capability-led activity to decision-led execution.
Mike Strassberg
Founder & Principal
A commercial operator with more than three decades building, scaling, and advising commercial organizations — across healthcare & life sciences, and alongside the agencies, consultancies, health-tech companies, AI vendors, and founder-led businesses selling into them.
The work spans commercialization strategy, business development, go-to-market architecture, product and AI strategy, sales enablement, and operating-model design. Built revenue organizations from plateau to multi-year growth. Stood up GTM motions for early-stage healthcare AI. Repositioned services firms for enterprise expansion. Advised executive teams through transformation, expansion, and capital events.
The Biomavens Method was built from what those engagements repeatedly revealed: the gap between capability and commercial traction is rarely a strategy problem. It is an operating problem — where signals, execution, and growth motion stop connecting. The Method is how that gap gets closed.
Engagements are led personally.
LinkedIn profile →How the work shows up across sectors.
Hardened in healthcare and life sciences — applied wherever decisions and execution have to improve together.
- —Capability → Buyer
- —Vendor → Advisor
- —Founder → System
- —Plateau → Growth
Operationalizing commercialization — not just recommending it.
Decks land. Markets don't move because of decks. Biomavens treats commercialization as an operating problem, not a strategic one.
Activity without architecture creates motion, not outcomes. Biomavens connects strategy, signals, and execution into a single operating cadence.
Commercialization works when people, process, platforms, and action align — the load-bearing foundation underneath every Biomavens engagement.